Tofacitinib and risk of cardiovascular outcomes: results from the Safety of Tofacitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study
Ann Rheum Dis. 2022 Jan 13. Epub ahead of print doi: 10.1136/annrheumdis-2021-221915
View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.
Ann Rheum Dis. 2022 Jan 13. Epub ahead of print doi: 10.1136/annrheumdis-2021-221915
N Engl J Med 2022;386:316–26. doi: 10.1056/NEJMc2202778
Rheumatol Ther. 2021. Epub ahead of print. doi: 10.1007/s40744-021-00390-0
J Clin Rheumatol. 2021;27(8):e482–e490
Ann Rheum Dis. 2021 Apr 27;80(8):1004–13.
Please click the links below to go to the CSF review of each paper
Lancet. 2021;398(10315):1984–96
Ann Rheum Dis. 2021;80(9):1130-1136
Int J Rheum Dis. 2021. Epub ahead of print
Clin Rheumatol. 2021. Epub ahead of print doi: 10.1007/s10067-021-05853-x